BOSTON SCIENTIFIC CORP (BSX.DE) Forecast, Price Target & Analyst Ratings

Name: BOSTON SCIENTIFIC CORP (BSX.DE) Analyst Consensus Rating
Brand: BOSTON SCIENTIFIC CORP
Rating: 8.5 (40 reviews)

FRA:BSX • US1011371077

60.2 EUR

-0.4 (-0.66%)

Last: Mar 23, 2026, 07:00 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BOSTON SCIENTIFIC CORP (BSX.DE).

Consensus Price Target

Price Target

€91.04

+ 51.23% Upside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: Apr 21, 2026
Period: Q1 / 2026
EPS Estimate: $0.80
Revenue Estimate: 5.227B

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

85.50%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

€91.04

Upside

+ 51.23%

From current price of €60.20 to mean target of €91.04, Based on 40 analyst forecasts

Low

€71.24

Median

€91.01

High

€110.64

Price Target Revisions

1 Month

-15.64%

3 Months

-16.54%

Price Target Summary

40 Wall Street analysts provided a forecast for the next 12 months for BSX.DE. The average price target is 91.04 EUR. This implies a price increase of 51.24% is expected in the next year compared to the current price of 60.2.

The average price target has been revised downward by 16.54% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

85.50%

BSX.DE was analyzed by 40 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about BSX.DE.

In the previous month the buy percentage consensus was at a similar level.

BSX.DE was analyzed by 40 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2021-07-28	Raymond James	Maintains	Strong Buy
2021-07-28	Credit Suisse	Maintains	Outperform
2021-07-28	Morgan Stanley	Maintains	Overweight
2021-05-26	Needham	Downgrade	Buy -> Hold
2021-05-25	Barclays	Initiate	Overweight
2021-04-29	Morgan Stanley	Maintains	Overweight
2021-04-15	Atlantic Equities	Initiate	Overweight
2021-02-12	Needham	Maintains	Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date: Apr 21, 2026
Period: Q1 / 2026
EPS Estimate: $0.80
Revenue Estimate: 5.227B
Revenue Q2Q: 12.10%
EPS Q2Q: 6.17%
Number of Analysts: 28

Next Earnings Revisions

Revenue (1 Month)

-0.10%

Revenue (3 Months)

-0.36%

EPS (1 Month)

-0.19%

EPS (3 Months)

-0.35%

Next Earnings Summary

BSX.DE is expected to report earnings on 4/21/2026. The consensus EPS estimate for the next earnings is 0.8 EUR and the consensus revenue estimate is 5.23B EUR.

The next earnings revenue estimate has been revised downward by 0.36% in the past 3 months.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032
Revenue YoY % growth	14.24B 12.29%	16.747B 17.61%	20.074B 19.87%	22.487B 12.02%	24.827B 10.41%	27.345B 10.14%	30.103B 10.09%	33.342B 10.76%	37.099B 11.27%	40.995B 10.50%
EBITDA YoY % growth	3.624B 13.00%	4.326B 19.37%	5.368B 24.09%	6.995B 30.31%	7.874B 12.57%	8.92B 13.28%	9.876B 10.72%	11.197B 13.38%	N/A	N/A
EBIT YoY % growth	2.428B 17.24%	3.057B 25.91%	4B 30.85%	6.283B 57.07%	6.992B 11.28%	7.896B 12.93%	9.048B 14.59%	10.134B 12.00%	N/A	N/A
Operating Margin	17.05%	18.25%	19.93%	27.94%	28.16%	28.88%	30.06%	30.39%	N/A	N/A
EPS YoY % growth	2.05 17.14%	2.51 22.44%	3.05 21.51%	3.50 14.65%	3.96 13.22%	4.44 12.12%	4.98 12.13%	5.65 13.53%	6.38 12.96%	7.12 11.55%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q1 / 26	Q2 / 26	Q3 / 26	Q4 / 26	Q1 / 27	Q2 / 27	Q3 / 27	Q4 / 27
EPS Q2Q % growth	0.80 6.17%	0.88 16.87%	0.88 17.15%	0.94 17.23%	0.90 12.76%	0.98 11.77%	0.99 12.68%	1.06 13.19%
Revenue Q2Q % growth	5.227B 12.10%	5.624B 11.12%	5.691B 12.36%	5.937B 12.32%	5.75B 10.01%	6.235B 10.86%	6.282B 10.38%	6.537B 10.11%
EBITDA Q2Q % growth	1.604B 26.50%	1.756B 8.46%	1.735B -15.53%	1.843B -23.69%	1.686B 5.11%	1.866B 6.26%	1.886B 8.70%	2.015B 9.33%
EBIT Q2Q % growth	1.456B 54.40%	1.602B 67.22%	1.615B 53.66%	1.72B 64.28%	1.616B 10.99%	1.786B 11.49%	1.821B 12.76%	1.944B 13.02%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

13.32%

EPS Next 5 Year

13.13%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

10.49%

Revenue Next 5 Year

10.46%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

16.70%

EBIT Next 5 Year

14.81%

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

BOSTON SCIENTIFIC CORP / BSX.DE Forecast FAQ

What is the average price target for BOSTON SCIENTIFIC CORP (BSX.DE) stock?

40 analysts have analysed BSX.DE and the average price target is 91.04 EUR. This implies a price increase of 51.24% is expected in the next year compared to the current price of 60.2.

What is the next earnings date for BSX stock?

BOSTON SCIENTIFIC CORP (BSX.DE) will report earnings on 2026-04-21, before the market open.

What are the consensus estimates for BOSTON SCIENTIFIC CORP (BSX.DE) next earnings?

The consensus EPS estimate for the next earnings of BOSTON SCIENTIFIC CORP (BSX.DE) is 0.8 EUR and the consensus revenue estimate is 5.23B EUR.

What is the number of analysts for BSX stock?

The number of analysts covering BOSTON SCIENTIFIC CORP (BSX.DE) is 40.

Analyst forecast overview

Forecast Snapshot